How does KO's 2024 performance compare to peers?

Coca-Cola's (KO) 2024 performance shows resilience amid various challenges, including a 2% volume decline in North America and currency headwinds impacting earnings. However, its total revenue of $47.06 billion for Q4 2024, with a 6% increase in organic revenues, indicates a robust foundation: 1. **Comparison with Peers**: - **PepsiCo (PEP)**: Pepsico's total revenue for Q4 2024 was $91.85 billion, significantly higher than Coca-Cola's $47.06 billion. This highlights PepsiCo's larger market presence and revenue base. - **Keurig Dr Pepper (KDP)**: With a total revenue of $15.35 billion for Q4 2024, Keurig Dr Pepper's figures are substantially lower than both Coca-Cola and PepsiCo's revenues. This suggests a more focused market presence or a narrower product portfolio compared to its competitors. - **Ginkgo Bioworks (DNA)**: Ginkgo Bioworks, operating in a different sector, had a total revenue of $227.04 million for Q4 2024. Its relatively small revenue compared to Coca-Cola and PepsiCo underscores the vast disparity in market size and financial scale among the companies. |code|Ticker|Name|Date|Total Revenue|market_code| |---|---|---|---|---|---| |KO|KO.N|The Coca-Cola|2024 Q1|1.13E10|169| |KDP|KDP.O|Keurig Dr Pepper|2024 Q1|3.468E9|185| |PEP|PEP.O|Pepsico|2024 Q1|1.825E10|185| |KO|KO.N|The Coca-Cola|2024 Q2|1.2363E10|169| |KDP|KDP.O|Keurig Dr Pepper|2024 Q2|3.922E9|185| |PEP|PEP.O|Pepsico|2024 Q2|2.2501E10|185| |KO|KO.N|The Coca-Cola|2024 Q3|1.1854E10|169| |KDP|KDP.O|Keurig Dr Pepper|2024 Q3|3.891E9|185| |PEP|PEP.O|Pepsico|2024 Q3|2.3319E10|185| |KO|KO.N|The Coca-Cola|2024 Q4|1.1544E10|169| 2. **Growth Focus**: - Coca-Cola's investment in Brazil, announced in May 2025, is a strategic move to capitalize on strong demand and potential for growth there. This expansion contrasts with challenges faced in North America, indicating a diversified approach to market development. - PepsiCo, with its higher revenue, may have a more established global presence and a broader range of products contributing to its revenue stream. - Keurig Dr Pepper's focus might be more concentrated on its core beverage segments, given its lower revenue compared to the others. 3. **Financial Health and Outlook**: - Coca-Cola's financial health, as indicated by its revenue and earnings growth, positions it well for future investments and market expansion. - PepsiCo's higher revenue suggests a strong financial position, potentially enabling more extensive market penetration and innovation. - Keurig Dr Pepper and Ginkgo Bioworks, with their lower revenues, might focus on optimizing their existing operations and product lines to improve profitability. In conclusion, while Coca-Cola shows a solid performance with a strong revenue base and strategic growth initiatives, its peers, especially PepsiCo, demonstrate a larger market presence and revenue scale. Each company's focus remains on optimizing their market positions and financial health.